NCT02076139 Safety and Immunogenicity of Nyaditum Resae® Probiotic to Protect From Tuberculosis Status COMPLETED Phase NA
NCT02075203 Evaluation of Safety, Immunogenicity, and Prevention of TB With AERAS-404 and BCG Revaccination in Healthy Adolescents Status COMPLETED Phase PHASE2
NCT02074956 A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 Administered in Adults Status COMPLETED Phase PHASE1
NCT02073240 Evaluation of an Enhanced Tuberculosis Infection Control Intervention in Healthcare Facilities in Vietnam and Thailand Status COMPLETED Phase N/A
NCT02066428 A Phase I Randomized Placebo-Controlled, Double-Blind Study to Evaluate Safety and Immunogenicity of AERAS-404 Administered as Different Amounts of Antigen and Adjuvant Combinations in HIV-Negative BCG-Vaccinated Adults Without Evidence of Tuberculosis Infection Status COMPLETED Phase PHASE1
NCT02045394 Epidemiology and Diagnosis of Haemoptysis: a Multicenter Study Status COMPLETED Phase N/A
NCT02043314 A Bioequivalence Study of Two Different Dosages of Isoniazid Tablet Formulations in Human Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02043067 Enhanced TB Screening to Determine the Prevalence and Incidence of TB in Patients With HIV Status COMPLETED Phase N/A
NCT02027480 Antiretroviral Therapy and Inflammatory and Coagulation Biomarkers: iMACS Study Status COMPLETED Phase N/A
NCT02021747 Biologic Basis Of Increased Susceptibility Of Smokers To Pulmonary Infection With Mycobacterium Tuberculosis Status WITHDRAWN Phase N/A
NCT02013245 Dose-Escalation Study to Evaluate the Safety and Immunogenicity of MTBVAC Vaccine in Comparison With BCG Vaccine. Status COMPLETED Phase PHASE1
NCT01990274 The Utility of Intensified Case Finding Combined With a Package of Novel TB Diagnostics Using a Mobile Clinic in Africa Status COMPLETED Phase NA
NCT01986543 Interaction Between High Dose Rifampicine and Efavirenz in Pulmonary Tuberculosis and HIV Co-infection Status UNKNOWN Phase PHASE2
NCT01979900 Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent Tuberculosis Status COMPLETED Phase PHASE3
NCT01960257 Wirelessly Observed Therapy in Comparison to Directly Observed Therapy for the Treatment of Tuberculosis Status COMPLETED Phase PHASE4